Na+, K+-ATPase inhibitor, ouabain accentuates irradiation damage in human tumour cell lines

Radiation Oncology Investigations

Volumn 6, Issue 3, 1998, Pages 109-119

  Verheye Dua, F ^a   Bohm L ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Irradiation; K+ ATPase; Na+; Ouabain; Tumour cells

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); COBALT 60; OUABAIN; RADIOSENSITIZING AGENT;

ANIMAL CELL; ARTICLE; ATAXIA TELANGIECTASIA; CANCER RADIOTHERAPY; CELL SURVIVAL; CONTROLLED STUDY; FIBROBLAST; GAMMA IRRADIATION; HELA CELL; HUMAN; HUMAN CELL; LUNG CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIOSENSITIVITY; TUMOR CELL LINE;

CELL LINE, TRANSFORMED; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0031842877     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1998)6:3<109::AID-ROI1>3.0.CO;2-1     Document Type: Article

References (34)

1. Boothman DA, Wang M, Schea RM, Burrows HL, Strickfaden A, Owens JK: Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radioresistant human malignant melanoma cells. Int J Radiat Oncol Biol Phys 24:939-948, 1992.
2. Foglesong PD, Reckord C, Swink S: Doxorubicin inhibits human DNA topoisomerase I. Cancer Chemother Pharmacol 30:123-125, 1992.
3. Becks WT, Danks MK: Mechanisms of resistance to drugs that inhibit DNA topoisomerases. Semin Cancer Biol 2:235-244, 1991.
4. Verheye-Dua F, Böhm L: Influence of ouabain on cell inactivation by irradiation. Strahlenther Onkol 172: 156-161, 1996.
5. Lawrence TS: Ouabain sensitizes tumor cells but not normal cells to radiation. Int J Radiat Oncol Biol Phys 15:953-958, 1988.
6. Lohrer HD, Tangen U, Anderson RF, Arrand JE: Characterization of a hybrid hamster-human cell line complemented for the Ataxia telangiectasia DNA repair defects. Pathobiology 62:140-148, 1994.
7. Fertil B, Dertinger H, Courdi A, Malaise EP: Mean inactivation dose: A useful concept for intercomparison of human cell survival curves. Radiat Res 99:73-84, 1984.
8. Deschavanne PJ, Fertil B: A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 34:251-266, 1996.
9. Jayanth VR, Bayne MT, Varnes ME: Effects of extracellular and intracellular pH on repair of potentially lethal damage, chromosome aberrations and DNA double-strand breaks in irradiated plateau-phase A549 cells. Radiat Res 139:152-162, 1994.
10. Nias AHW: An Introduction to Radiobiology. Chichester, England: John Wiley and Sons, 1990.
11. Deacon J, Peckham MJ, Steel G: The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol 2:317-323, 1984.
12. Deschavanne PJ, Debieu D, Fertil B, Malaise EP: Reevaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins. Int J Radiat Biol 50:279-293, 1986.
13. Steel GG, Peacock JH: Why are some human tumours more radiosensitive than others? Radiother Oncol 15: 63-72, 1989.
14. Hall EJ, Brenner DJ: Sublethal damage repair rates: A new tool for improving therapeutic ratios? Int J Radiat Oncol Biol Phys 30:241-242, 1994.
15. Peacock JH, Cassoni AM, McMillan TJ, Steel GG: Radiosensitive human tumour cell lines may not be recovery deficient. Int J Radiat Biol 54:945-953, 1988.
16. Gupta RS, Chopra A, Stetsko DK: Cellular basis for the species differences in sensitivity to cardiac glycosides (Digitalis). J Cellul Physiol 127:197-206, 1986.
17. Deschavanne PJ, Fertil B, Chavaudra N, Malaise EP: The relationship between radiosensitivity and repair of potentially lethal damage in human tumor cell lines with implications for radioresponsiveness. Radiat Res 122:29-37, 1990.
18. Matthews JHL, Meeker BE, Chapman JD: Response of human tumor cell lines in vitro to fractionated irradiation. Int J Radiat Oncol Biol Phys 16:133-138, 1989.
19. Kysela BP, Lohrer H, Arrand JE: Defects in the kinetics of the repair of DNA double-strand breaks and inhibition of DNA synthesis in the Ataxia Telangiectasia AT5BI-VA cell line: Comparison to a corrected hybrid, atxbc. Radiat Res 144:276-281, 1995.
20. Hall EJ, Marchese M, Hei TK, Zaider M: Radiation response characteristics of human cell in vitro. Radiat Res 114:415-424, 1988.
21. Brenner DJ, Hall EJ, Huang Y, Sachs RK: Optimizing the time course of brachytherapy and other accelerated radiotherapeutic protocols. Int J Radiat Oncol Biol Phys 29:893-901, 1994.
22. Cox JD, Pajak TF, Marcial VF, Coia F, Mohiuddin M, Fu KK, Selim H, Rubin P, Ortiz H, the Radiation Therapy Oncology Group 1991: Astro plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group Protocol 8313. Int J Oncol Biol Phys 20:1191-1195, 1991.
23. Turesson I, Thames HD: Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother Oncol 15:169-188, 1989.
24. Pohlit W, Heyder IH: The shape of dose-survival curves for mammalian cells and repair of potentially lethal damage analyzed by hypertonic treatment. Radiat Res 87:613-634, 1981.
25. Wheeler KT, Nelson GB: Saturation of a DNA repair process in dividing and nondividing mammalian cells. Radiat Res 109:109-117, 1987.
26. Reddy NMS, Mayer PJ, Lange CS: The saturation repair kinetics of Chinese Hamster V79 cells suggests a damage accumulation-interaction model of cell killing. Radiat Res 121:304-311, 1990.
27. Brenner DJ, Hall EJ: Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 20:181-190, 1991.
28. Weichselbaum RR, Schmitt A, Little JB: Cellular repair factors influencing radiocurability of human malignant tumours. Br J Cancer 45:10-16, 1982.
29. Bedford JS: Sublethal damage, potentially lethal damage, and chromosomal aberrations in mammalian cells exposed to ionizing radiation. Int J Radiat Oncol Biol Phys 21:1457-1469, 1991.
30. Varnes ME, Dethlefsen LE, Biaglow JE: The effect of pH on potentially lethal damage recovery in A549 cells. Radiat Res 108:80-90, 1986.
31. Thews O, Zywietz F, Lecher B, Vaupel P: Oxygenierung und bioenergetischer/metabolisher Status des Rhabdomyosarkoms der Ratte nach fraktionierter Bestrahlung (abstract). Strahlenther Onkol 173:626, 1997.
32. Zywietz F, Reeker W, Kochs E: Tumor oxygenation in a transplanted rat rhabdomyosarcoma during fractionated irradiation. Int J Radiat Oncol Biol Phys 32:1391-1400, 1995.
33. Rolfe DFS, Brown GC: Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 77:731-758, 1997.
34. Withers HR, Peters LJ: Basic principles of radiotherapy. In: Fletcher GH (ed): Textbook of Radiotherapy. Philadelphia: Lea and Febiger, pp 103-175, 1980.